ArticleInternal medicine (Tokyo, Japan)2026
Clinico-epidemiological Characteristics of Helicobacter pylori-naïve Undifferentiated Gastric Cancer.
Article in Internal medicine (Tokyo, Japan), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Population-Based Gastric Cancer Screening in Japan: Evolution, Challenges, and Lessons for Implementation.Cancer control : journal of the Moffitt Cancer CenterReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective Understanding the prevalence of screening targets is essential for optimizing cancer-screening strategies. However, the precise clinicoepidemiological characteristics of Helicobacter pylori-naïve gastric cancer (H. pylori-naïve GC), especially the undifferentiated type, remain unknown. We herein aimed to confirm the clinicopathological characteristics of H. pylori-naïve patients with undifferentiated GC in Japan. Methods This retrospective cross-sectional study used a database of esophagogastroduodenoscopies (EGDs) from 12 Japanese institutions (2016-2022). Patients who underwent EGD as part of their health monitoring were analyzed for the prevalence and clinical characteristics of H. pylori-naïve undifferentiated GC, including pure signet ring cell carcinoma (PSRCC) and por/sig lesions. The previous EGD images were reviewed to estimate the rate of missed lesions. Results Among 222,656 individuals, 35 PSRCC and 7 por/sig lesions were identified (prevalence: 0.020% and 0.003%, respectively). Por/sig lesions were more frequently located in the upper half of the stomach than were PSRCC lesions (71.4% vs. 40.0%, p=0.040). All PSRCC lesions were classified as pT1a, whereas 71.4% of por/sig lesions were pT1b or deeper, and 57.1% required surgery. Furthermore, 44.4% of PSRCC lesions were missed during previous EGDs, whereas none of the por/sig lesions were overlooked. Conclusion The prevalence of undifferentiated H. pylori-naïve GC was low. Compared with PSRCC, por/sig lesions were diagnosed at a more advanced stage and were not identified during previous examinations, highlighting their difficulty in detection during routine EGD screening. These findings underscore the need to revise EGD screening strategies, particularly in populations with a low prevalence of H. pylori infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.